Market Structure of the Turkish Pharmaceutical Industry
Yıl: 2018 Cilt: 9 Sayı: 3 Sayfa Aralığı: 449 - 462 Metin Dili: İngilizce DOI: 10.20409/berj.2018.116 İndeks Tarihi: 16-01-2020
Market Structure of the Turkish Pharmaceutical Industry
Öz: The market structure of the Pharmaceutical Industry, which has an extremelyimportant both socially and economically position, is carefully monitored by regulatoryauthorities. The consantration of pharmaceutical companies tends to adversely affectconsumer welfare as well as resource distribution in the economy. The competitivestructure of the markets is determined by the concentration indices. For these reasons,in this study the market concentration ratios of the pharmaceutical sector in Turkey arecalculated by using concentration measures such as Concentration Ratio; HerfindahlHirschman; Hall-Tideman; Rosenbluth; Comprehensive Industrial Concentration;Hannah-Kay; Hause and the Entropy measure with the annual sales revenue data of thecompanies in the sector for the 2009-2016 period.According to the results,pharmaceutical sector in Turkey has a low concentrated market structure. In addition,the Rosenbluth index presents the most consistent results for the Turkishpharmaceutical sector, which consists of hundreds of small companies having marketsshares of 7% at the highest.
Anahtar Kelime: Konular:
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- Araştırmacı İlaç Firmaları Derneği (AIFD) (2012). Türkiye ilaç sektörü vizyon 2023 raporu.
- Bain, J. S. (1959). Industrial organization. New York: John Wiley & Sons Press.
- Balili, L. (2016). Analyzing competition in pharmaceutical sector–with a case study of Albania. European Scientific Journal, 12(15),132-142.
- Bikker, J. A., & Haaf, K. (2002). Measures of competition and concentration in the banking industry: A review of the literature. Economic & Financial Modelling, 9(2): 53-98.
- Chen, L., & Huaizhou, T. (2001). The study of market concentration of pharmaceutical industry in China. China Pharmacy, 1, 001-012.
- Davies, S. (1979). Choosing between Concentration Indices: The iso-concentration curve. Economica, 46(181),67-75. Doi:10.2307/2553097
- De Vany, A,. & Kim, C. L. H. (2003). Stochastic market structure: Concentration measures and motion picture antitrust. No. 30701. University of Manchester, Institute for Development Policy and Management (IDPM).
- Finkelstein, M. O., & Friedberg, R. M. (1967). The application of an entropy theory of concentration to the Clayton Act. The Yale Law Journal, 76(4), 677-717.
- Fiuza, E. PS, & Lisboa, M.de B. (2003). Credence goods and market power: An econometric study on the Brazilian pharmaceutical industry. Estudos Econômicos, 33(4), 601-638.
- Grabowski, H. G., & Vernon, J. M. (1976). Structural effects of regulation on innovation in the ethical drug industry. Essays on industrial organization, in honor of Joe S. Bain.
- Hall, M., & Tideman, N. (1967). Measures of concentration. Journal of the American Statistical Association, 62(317), 162- 168.
- Hannah, L., & Kay, J. A. (1977). Concentration in modern industry: Theory, measurement and the UK experience. Springer.
- Hart, P.E. (1971). Entropy and other measures of concentration, Journal of the Royal Statistical Society, 134, 73-85.
- Hause, J. C. (1977). The measurement of concentrated industrial structure and the size distribution of firms. Annals of Economic and Social Measurement, 6(1), 73-107.
- Hennessy, D. A., & Lapan, H. (2007). When different market concentration indices agree. Economics Letters, 95(2), 234- 240.
- Horvath, J. (1970). Suggestion for a comprehensive measure of concentration. Southern Economic Journal, 36(4), 446- 452.
- Jacquemin, A. (1987). The new industrial organization. Cambridge, Mass.: MIT Press.
- Jacquemin, A. P., & Phlips, L. (1976). Concentration, size and performance of European firms. In Markets, corporate behaviour and the state, 55-77. Boston, MA: Springer
- Kassalis, I. (2010). Cluster-Based Approach: A tool to enter into the market In Business and Management 2010, conference selected papers. Vilnius, 635-642.
- Kaynak, S. (2016). Türk ilaç sektörünün rekabet yapısı ve yoğunlaşma analizi. Çankırı Karatekin Üniversitesi İİBF Dergisi, 6(2), 49-66.
- Koch, James V. (1980). Industrial Organization and Prices. Englewood Cliffs, NJ: Prentice-Hall.
- Kontozamanis, V., Mantzouneas, E., & Stoforos, C. (2003), An overview of the Greek pharmaceutical market. Eur. J. Health Econ., (4), 327–333
- Lall, S. (1979). Multinational Companies and Concentration: The Case of the Pharmaceutical Industry. Social Scientist, 7(8/9), 3-29. Doi:10.2307/3516706
- Marfels, C. (1971). Absolute and relative measures of concentration reconsidered. Kyklos 24, 753-766.
- Marfels, C. (1972). The consistency of concentration measures: A mathematical evaluation. Journal of Institutional and Theoretical Economics, 196-215.
- Matraves, C. (1999). Market structure, R&D and advertising in the pharmaceutical industry. The Journal of Industrial Economics, 47(2), 169-194.
- Mehta, A., Farooqui, H. H., & Selvaraj S. (2016). A critical analysis of concentration and competition in the Indian pharmaceutical market. PloS one, 11(2), e0148951.
- QuintilesIMS, Turkish Pharmaceutical Index 2009-2016 Rosenbluth, G. (1955). Measures of concentration. Business concentration and price policy. Princeton University Press, 57-99.
- Scherer, F.M. (1990). Industrial market structure and economic performance. Boston.
- Schwartzman, D. (1976). Innovation in the pharmaceutical industry, Johns Hopkins University Press.
- Sharp, M., Patel, P., & Pavitt, K. (1996). Europe's pharmaceutical industry: an innovation profile. European Commission.
- Shy, O. (1995). Industrial organization: theory and applications. MIT press.
- Slatter, S. St. P. (1977). Competition and marketing strategies in the pharmaceutical industry. London, Croom Helm.
- Stigler, G.J. (1964). A theory of oligopoly. Journal of Political Economy, 72, 44-61.
- Sweeny, K. (2007a). The pharmaceutical industry in Australia. Working Paper No. 34, Centre for Strategic Economic Studies, Victoria University of Technology, Melbourne.
- Sweeny, K. (2007b). Trends and outcomes in the Australian pharmaceutical benefits scheme. Pharmaceutical Industry Project Working Paper No. 36, December, Centre for Strategic Economic Studies, Victoria University, Melbourne
- Theil, H. (1967). Economics and information theory, Studies in Mathematical and Managerial Economics. Noord- Holland Publishing Company.
- Tirole, J. (1988). The theory of industrial organization. Cambridge, Mass.
- Tushar, M. (2016). Determinants of market concentration and market power in Indian Pharmaceutical Industry. DOI: 10.13140/RG.2.1.4799.4086
- U.S. Department of Commerce (2016). ITA pharmaceuticals top markets reports country case study: Turkey, May 2016.
- U.S. Department of Justice, Merger Guidelines (1968).
- U.S. Department of Justice, Merger Guidelines (1982).
- Vernon, J. (1971). Concentration, promotion, and market share stability in the pharmaceutical industry. The Journal of Industrial Economics, 19(3), 246-266. Doi:10.2307/2097429
- White, A.P. (1982). A note on market structure measures and the characteristics of the markets that they ‘measure’. Southern Economic Journal, 49 (02), 542-549. Doi10.2307/1058503
| APA | İpek E, IPEK O (2018). Market Structure of the Turkish Pharmaceutical Industry. , 449 - 462. 10.20409/berj.2018.116 |
| Chicago | İpek Egemen,IPEK Ozlem Market Structure of the Turkish Pharmaceutical Industry. (2018): 449 - 462. 10.20409/berj.2018.116 |
| MLA | İpek Egemen,IPEK Ozlem Market Structure of the Turkish Pharmaceutical Industry. , 2018, ss.449 - 462. 10.20409/berj.2018.116 |
| AMA | İpek E,IPEK O Market Structure of the Turkish Pharmaceutical Industry. . 2018; 449 - 462. 10.20409/berj.2018.116 |
| Vancouver | İpek E,IPEK O Market Structure of the Turkish Pharmaceutical Industry. . 2018; 449 - 462. 10.20409/berj.2018.116 |
| IEEE | İpek E,IPEK O "Market Structure of the Turkish Pharmaceutical Industry." , ss.449 - 462, 2018. 10.20409/berj.2018.116 |
| ISNAD | İpek, Egemen - IPEK, Ozlem. "Market Structure of the Turkish Pharmaceutical Industry". (2018), 449-462. https://doi.org/10.20409/berj.2018.116 |
| APA | İpek E, IPEK O (2018). Market Structure of the Turkish Pharmaceutical Industry. Business and Economics Research Journal, 9(3), 449 - 462. 10.20409/berj.2018.116 |
| Chicago | İpek Egemen,IPEK Ozlem Market Structure of the Turkish Pharmaceutical Industry. Business and Economics Research Journal 9, no.3 (2018): 449 - 462. 10.20409/berj.2018.116 |
| MLA | İpek Egemen,IPEK Ozlem Market Structure of the Turkish Pharmaceutical Industry. Business and Economics Research Journal, vol.9, no.3, 2018, ss.449 - 462. 10.20409/berj.2018.116 |
| AMA | İpek E,IPEK O Market Structure of the Turkish Pharmaceutical Industry. Business and Economics Research Journal. 2018; 9(3): 449 - 462. 10.20409/berj.2018.116 |
| Vancouver | İpek E,IPEK O Market Structure of the Turkish Pharmaceutical Industry. Business and Economics Research Journal. 2018; 9(3): 449 - 462. 10.20409/berj.2018.116 |
| IEEE | İpek E,IPEK O "Market Structure of the Turkish Pharmaceutical Industry." Business and Economics Research Journal, 9, ss.449 - 462, 2018. 10.20409/berj.2018.116 |
| ISNAD | İpek, Egemen - IPEK, Ozlem. "Market Structure of the Turkish Pharmaceutical Industry". Business and Economics Research Journal 9/3 (2018), 449-462. https://doi.org/10.20409/berj.2018.116 |
